Use of embolic protection devices during saphenous vein graft (SVG) interventions is associated with an increase in procedural complications without corresponding improvements in clinical outcomes for ...

Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...

CHICAGO, IL—Cerebral embolic protection devices are infrequently used during transcatheter aortic valve implantation procedures in the United States, and new data suggest their use does not appear to ...

A multicenter EPIC (FiberNet Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System had a 97.5 percent success rate when used in patients ...

Dublin, Nov. 12, 2021 (GLOBE NEWSWIRE) -- The "Peripheral Embolic Protection Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" report has been added to ...

WASHINGTON, DC — Are surrogate end points enough to recommend a treatment that seems safe but hasn't "worked" by clinical-trial standards, but many agree ought to work? A pair of catheter-delivered ...

WASHINGTON, DC — An embolic-protection device delivered percutaneously via the radial artery and used during transcatheter aortic-valve implantation (TAVI) in high-risk patients with aortic stenosis ...

United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...

ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Recently published research shows that a medical device may be beneficial for patients who have previously had a stroke and are planning to undergo a transcatheter aortic valve replacement, a type of ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, ...

Transcatheter aortic valve replacement (TAVR) is revolutionizing the treatment of aortic valve stenosis, offering a minimally invasive option for patients suffering from this heart condition. However, ...